These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2088196)

  • 1. Inhibition of amphotericin B (Fungizone) toxicity to cells by egg lecithin-glycocholic acid mixed micelles.
    Brajtburg J; Elberg S; Kobayashi GS; Medoff G
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2415-6. PubMed ID: 2088196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the leishmanicidal activity of fungizone, liposomal AmB and amphotericin B incorporated into egg lecithin-bile salt mixed micelles.
    Ramos H; Brajtburg J; Marquez V; Cohen BE
    Drugs Exp Clin Res; 1995; 21(6):211-6. PubMed ID: 8907695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of murine candidiasis and cryptococcosis with amphotericin B incorporated into egg lecithin-bile salt mixed micelles.
    Brajtburg J; Elberg S; Travis SJ; Kobayashi GS
    Antimicrob Agents Chemother; 1994 Feb; 38(2):294-9. PubMed ID: 8192455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphotericin B incorporated into egg lecithin-bile salt mixed micelles: molecular and cellular aspects relevant to therapeutic efficacy in experimental mycoses.
    Brajtburg J; Elberg S; Kobayashi GS; Bolard J
    Antimicrob Agents Chemother; 1994 Feb; 38(2):300-6. PubMed ID: 8192456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphotericin B and amphotericin B methyl ester ascorbate. I. Chemotherapeutic activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in mice.
    Gadebusch HH; Pansy F; Klepner C; Schwind R
    J Infect Dis; 1976 Nov; 134(5):423-7. PubMed ID: 792355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the effects of liposomal amphotericin B on Candida albicans, Cryptococcus neoformans, and erythrocytes by using small unilamellar vesicles prepared from saturated phospholipids.
    Jullien S; Contrepois A; Sligh JE; Domart Y; Yeni P; Brajtburg J; Medoff G; Bolard J
    Antimicrob Agents Chemother; 1989 Mar; 33(3):345-9. PubMed ID: 2658784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
    Gangadhar KN; Adhikari K; Srichana T
    Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
    Rossi SA; de Oliveira HC; Agreda-Mellon D; Lucio J; Mendes-Giannini MJS; García-Cambero JP; Zaragoza O
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.
    Hoeprich PD; Huston AC
    J Infect Dis; 1975 Aug; 132(2):133-41. PubMed ID: 1099147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system.
    Tabosa Do Egito ES; Appel M; Fessi H; Barratt G; Puisieux F; Devissaguet JP
    J Antimicrob Chemother; 1996 Sep; 38(3):485-97. PubMed ID: 8889723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of antifungal antibiotics on some determinants of virulence in Candida albicans and Cryptococcus neoformans cells.
    Borowski J; Jakoniuk P; Jablońska W; Jakubicz W; Szpak A
    Experientia; 1974 Oct; 30(10):1210-1. PubMed ID: 4611784
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.
    Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R
    J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology.
    Keele DJ; DeLallo VC; Lewis RE; Ernst EJ; Klepser ME
    Diagn Microbiol Infect Dis; 2001 Nov; 41(3):121-6. PubMed ID: 11750164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.
    Espuelas MS; Legrand P; Campanero MA; Appel M; Chéron M; Gamazo C; Barratt G; Irache JM
    J Antimicrob Chemother; 2003 Sep; 52(3):419-27. PubMed ID: 12888593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B.
    Anaissie E; Paetznick V; Proffitt R; Adler-Moore J; Bodey GP
    Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):665-8. PubMed ID: 1748123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ascorbic acid on the antifungal action of amphotericin B.
    Brajtburg J; Elberg S; Kobayashi GS; Medoff G
    J Antimicrob Chemother; 1989 Sep; 24(3):333-7. PubMed ID: 2681119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin and rutin as potential agents antifungal against Cryptococcus spp.
    Oliveira VM; Carraro E; Auler ME; Khalil NM
    Braz J Biol; 2016; 76(4):1029-1034. PubMed ID: 27166572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization and toxicity evaluation of amphotericin B loaded MPEG-PCL micelles and its application for buccal tablets.
    Zhang P; Yang X; He Y; Chen Z; Liu B; Emesto CS; Yang G; Wang W; Zhang J; Lin R
    Appl Microbiol Biotechnol; 2017 Oct; 101(19):7357-7370. PubMed ID: 28868587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans.
    Ghannoum MA; Fu Y; Ibrahim AS; Mortara LA; Shafiq MC; Edwards JE; Criddle RS
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2459-65. PubMed ID: 8585726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.